MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopamine receptor"

  • 2026 International Congress

    Receptor Selectivity Profile and Clinical Significance of Ecopipam and Its Metabolites as a Potential Therapy for Tourette Syndrome

    S. Wanaski, V. Schmith, G. Karkanias, T. Cunniff (Chicago, USA)

    Objective: To characterize the binding/inhibition and potential clinical relevance of ecopipam and its metabolites across a wide array of potential off-target receptors, ion channels, enzymes,…
  • 2026 International Congress

    Exposure-Response Analysis of Glovadalen in the ATLANTIS Phase II Study: Trial Simulation Explains Dose-Response for OFF Time in Parkinson’s

    D. Menshykau, M. Biagioni, C. Beuter, C. Legendre, A. Benoit, L. Vroye, B. Klünder, M. Faisal, S. Leach, R. Nicholl, H. Naik (Monheim am Rhein, Germany)

    Objective: This analysis characterized the exposure-response (E-R) relationship of glovadalen (UCB0022) in the ATLANTIS Phase-IIa proof-of-concept study, to understand the apparent lack of dose-response for…
  • 2026 International Congress

    Synuclein and dopamine transporter biomarkers among phenoconverters to parkinsonian disorders

    C. Simonet, J. Yin, L. Chahine, D. Weintraub, K. Chatterjee, C. Caspell-Garcia, D-E. Lafontant, A. Noyce, T. Simuni (London, United Kingdom)

    Objective: To describe and assess biological congruency, defined as expected biological profile based on abnormal CSF α-synuclein Seed Amplification Assays (CSFaSynSAA) and dopamine transporter SPECT…
  • 2026 International Congress

    Ion Channel Modulation by Dopamine Receptors in Subthalamic Nucleus Neurons: Implications for Parkinson’s Disease Pathophysiology

    C. Mahapatra (Pessac, France)

    Objective: Recent neurophysiological studies indicate that dopamine D2 receptors (D2R) may interact with N-type calcium channels in neurons of the subthalamic nucleus (STN), potentially altering…
  • 2026 International Congress

    Low-dose ketamine reduces dopamine 2 receptor-like agonist-induced dyskinesia in a preclinical model

    T. Falk, R. Parmar, J. Meredith, J. Castro, E. Smith, M. Bartlett, S. Sherman (Tucson, USA)

    Objective: Preclinical evaluation of low-dose ketamine treatment on dyskinesia induced by direct or indirect striatofugal pathway activation. Background: Ketamine infusions are effective therapy for depression…
  • 2024 International Congress

    Dopaminergic alterations in patients with Alzheimer’s disease

    M. Azharuddin, M. Sharma (New Delhi, India)

    Objective: The objective of this study was to conduct a meta-analysis to determine the pooled mean difference (MD) in dopaminergic measures between Alzheimer’s disease and…
  • 2024 International Congress

    In Silico Electrophysiology and System Pharmacology Reveal Coupling Between Dopamine Receptors and Ca2+ Channels in Subthalamic Neuronal Cells towards Parkinson’s Disease

    C. Mahapatra (Mumbai, India)

    Objective: Recent experimental evidence suggests a potential interaction between dopamine D2 receptors (D2R) and N-type Ca2+ channels, impacting the firing patterns of Subthalamic neuronal (STN)…
  • 2023 International Congress

    Long-term safety and durability of effect of ecopipam in pediatric patients with Tourette Syndrome: Results of a 12-month open-label extension (OLE) study

    D. Gilbert, D. Kim, M. Miller, S. Horine, K. Saljooqi, G. Karkanias, S. Wanaski, T. Cunniff (Cincinnati, USA)

    Objective: Assess the safety and durability of effect of long-term treatment with ecopipam in pediatric patients with Tourette syndrome (TS). Background: TS is a childhood-onset…
  • 2023 International Congress

    Dopamine Receptor Gene Polymorphism in L-Dopa Induced Dyskinesia- A Study from Eastern India

    S. Sarkar, S. Choudhury, S. Ansari, R. Banerjee, S. Dey, H. Kumar (Kolkata, India)

    Objective: We intended to find the frequency of Single Nucleotide Polymorphism (SNP) rs6280 in DRD3 gene in PD patients with and without Levodopa Induced Dyskinesia…
  • 2023 International Congress

    Identification of xylopropamine as a potential dopamine D2 receptor agonist through computational drug discovery pipeline

    B. Ugbedeojo, P. Adoyi, A. Abah, O. Onimisi, S. Musa, A. Omoniyi (Zaria, Nigeria)

    Objective: This study aims to identify novel dopamine D2 receptor agonists through the computational drug discovery pipeline. Background: Parkinson's disease (PD) is a neurodegenerative disorder…
  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley